Skip to main content
. 2020 Mar 15;12(3):268. doi: 10.3390/pharmaceutics12030268

Table 3.

Inhibition potential of DWP16001, dapagliflozin, and ipragliflozin on SGLT1 and SGLT2 activities.

IC50 (nM) Selectivity
SGLT1 SGLT2 (IC50 Ratio of SGLT1/SGLT2)
DWP16001 549.3 ± 139.6 0.8 ± 0.3 667
Ipragliflozin 2328.7 ± 377.6 8.9 ± 1.7 261
Dapagliflozin 803.0 ± 96.8 1.6 ± 0.3 493

Data were expressed as mean ± SD from triplicate measurement.